BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 12904069)

  • 21. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
    Hirokawa Y; Kinoshita H; Tanaka T; Nakata K; Kitadai N; Fujimoto K; Kashimoto S; Kojima T; Kato S
    J Med Chem; 2008 Apr; 51(7):1991-4. PubMed ID: 18330977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
    Ellsworth EL; Tran TP; Showalter HD; Sanchez JP; Watson BM; Stier MA; Domagala JM; Gracheck SJ; Joannides ET; Shapiro MA; Dunham SA; Hanna DL; Huband MD; Gage JW; Bronstein JC; Liu JY; Nguyen DQ; Singh R
    J Med Chem; 2006 Nov; 49(22):6435-8. PubMed ID: 17064062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
    Hossion AM; Zamami Y; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Sasaki K
    J Med Chem; 2011 Jun; 54(11):3686-703. PubMed ID: 21534606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleuromutilin derivatives having a purine ring. Part 1: new compounds with promising antibacterial activity against resistant Gram-positive pathogens.
    Hirokawa Y; Kinoshita H; Tanaka T; Nakamura T; Fujimoto K; Kashimoto S; Kojima T; Kato S
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3556-61. PubMed ID: 18511280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.
    Angehrn P; Buchmann S; Funk C; Goetschi E; Gmuender H; Hebeisen P; Kostrewa D; Link H; Luebbers T; Masciadri R; Nielsen J; Reindl P; Ricklin F; Schmitt-Hoffmann A; Theil FP
    J Med Chem; 2004 Mar; 47(6):1487-513. PubMed ID: 14998336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
    Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antibacterial activity of novel pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid derivatives carrying the 3-cyclopropylaminomethyl-4-substituted-1-pyrrolidinyl group as a C-10 substituent.
    Asahina Y; Takei M; Kimura T; Fukuda Y
    J Med Chem; 2008 Jun; 51(11):3238-49. PubMed ID: 18457383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on 6-aminoquinolones: synthesis and antibacterial evaluation of 6-amino-8-methylquinolones.
    Cecchetti V; Fravolini A; Lorenzini MC; Tabarrini O; Terni P; Xin T
    J Med Chem; 1996 Jan; 39(2):436-45. PubMed ID: 8558512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.
    Mitscher LA
    Chem Rev; 2005 Feb; 105(2):559-92. PubMed ID: 15700957
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives.
    Foroumadi A; Emami S; Hassanzadeh A; Rajaee M; Sokhanvar K; Moshafi MH; Shafiee A
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4488-92. PubMed ID: 16105736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.
    Okumura R; Hirata T; Onodera Y; Hoshino K; Otani T; Yamamoto T
    J Antimicrob Chemother; 2008 Jul; 62(1):98-104. PubMed ID: 18390884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antibacterial activity of substituted 1,2,3,4-tetrahydropyrazino [1,2-a] indoles.
    Tiwari RK; Singh D; Singh J; Yadav V; Pathak AK; Dabur R; Chhillar AK; Singh R; Sharma GL; Chandra R; Verma AK
    Bioorg Med Chem Lett; 2006 Jan; 16(2):413-6. PubMed ID: 16246547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological activity of novel antibacterial quinazolines.
    Bedi PM; Kumar V; Mahajan MP
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5211-3. PubMed ID: 15380229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
    Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antibacterial activity of 3-O-carbamoyl derivatives of 6,11-di-O-methylerythromycin A: a novel class of acylides.
    Wu Z; Lu Y; Luo M; He X; Xiao Y; Yang J; Pan Y; Qiu G; Guo H; Hu H; Zhou D; Hu X
    Eur J Med Chem; 2010 Sep; 45(9):3636-44. PubMed ID: 20554083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antibacterial activity of some aryloxy/thioaryloxy oxazolidinone derivatives.
    Arora V; Salunkhe MM; Sinha N; Sinha RK; Jain S
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4647-50. PubMed ID: 15324881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationships in quinolone antibacterials: design, synthesis and biological activities of novel isothiazoloquinolones.
    Chu DT; Fernandes PB; Claiborne AK; Shen L; Pernet AG
    Drugs Exp Clin Res; 1988; 14(6):379-83. PubMed ID: 2850902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antibacterial property of pyrrolopyrano quinolinones and pyrroloquinolines.
    Jayagobi M; Raghunathan R; Sainath S; Raghunathan M
    Eur J Med Chem; 2011 Jun; 46(6):2075-82. PubMed ID: 21444131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antibacterial activity of the 4-quinolone-3-carboxylic acid derivatives having a trifluoromethyl group as a novel N-1 substituent.
    Asahina Y; Araya I; Iwase K; Iinuma F; Hosaka M; Ishizaki T
    J Med Chem; 2005 May; 48(9):3443-6. PubMed ID: 15857152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and in vitro activity of a series 1beta-methylcarbapenem derivatives.
    Jeon HC; Kim JW; Hong JH; Cho JH; Oh CH
    Eur J Med Chem; 2006 Oct; 41(10):1201-9. PubMed ID: 16797791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.